New Delhi, 13 Feb 2024: In a bid to protect consumers from the risks due to poor quality of medicines, cosmetics and medical devices, the Drug Controller General of India (DCGI) has asked the state drug inspectors to maintain a spurious drug list and publish it on monthly basis t......
View Details

Related News

• DoP re-opens application window for API CF sub-scheme (14-12-2024)

---

• Nursing colleges scam: MP HC orders removal of top officials (14-12-2024)

---

• 1.5L antibiotic tablets supplied to Nanded govt hosp spurious (14-12-2024)

---

• Didn't find sugar norms flouted in Nestle baby food: J P Nadda in LS (14-12-2024)

---

• Fake degrees seized from pvt institute in Hisar (13-12-2024)

---

• Health ministry assign testing labs for surgical and medical examination gloves (13-12-2024)

---

• DCGI asks States to approve all applications for medicines and medical devices for rare diseases within three months (13-12-2024)

---

• Karnataka to restructure drugs control dept, strengthen procedures (13-12-2024)

---

• US FDA identifies cases of liver injury after treatment with Intercept's Ocaliva (obeticholic acid) (13-12-2024)

---

• Fake platelets sold for 15 thousand rupees in Prayagraj, CMO ordered an inquiry (12-12-2024)

---